cyclotriphosphazene ester has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JK; Sohn, YS; Song, R; Toti, US | 1 |
| Baek, H; Cho, Y; Lee, CO; Sohn, YS | 1 |
2 other study(ies) available for cyclotriphosphazene ester and Leukemia L 1210
| Article | Year |
|---|---|
A macromolecular prodrug of doxorubicin conjugated to a biodegradable cyclotriphosphazene bearing a tetrapeptide.
Topics: Animals; Antibiotics, Antineoplastic; Biodegradation, Environmental; Cell Line, Tumor; Doxorubicin; Inhibitory Concentration 50; Leukemia L1210; Magnetic Resonance Spectroscopy; Molecular Weight; Nitriles; Oligopeptides; Phosphorus Compounds; Polyethylene Glycols; Prodrugs; Stereoisomerism | 2005 |
Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugates.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Nitriles; Organoplatinum Compounds; Phosphorus Compounds; Tumor Cells, Cultured | 2000 |